lost flu sales weigh on roche and other pharmas in q1
roche  is set to kick off the big pharma reporting season with a fall in sales on thursday as a strong swiss franc, weak demand for top-selling cancer drug avastin and lack of tamiflu revenue take their toll.
http://feeds.reuters.com/~r/reuters/businessnews/~3/pwf00fomlt4/us-roche-idustre73a3qj20110411
5201
11 Apr 2011 16:52:18
reuters
business